All Report
Whether you’re exploring new opportunities, responding to change, or planning your next move—we’re here to help you make sense of it all. Our research goes beyond data to uncover real market signals, emerging trends, competitive shifts, and what they mean for your business. With practical insights and a partner mindset, we support you in making smarter, faster, and more confident decisions.
The global ultrasonic electrosurgical devices market is projected to reach USD 5.5 billion in 2025, expanding to USD 9 billion by 2035, with a CAGR of 7.1% during the forecast period.
The global ultrasound biometry devices market is set to grow significantly, reaching a valuation of USD 268.1 million by 2025, with projections to hit USD 378.1 million by 2035.
The global ultrasound conductivity gels market is projected to reach USD 326.9 million in 2025 and expand to USD 691.7 million by 2035, reflecting a CAGR of 8.8% over the forecast period.
The global ultrasound devices market is set to witness substantial growth, reaching USD 7.6 billion by 2025, with projections to hit USD 11.6 billion by 2035. The market is expected to expand at a CAGR of 8.0% over the forecast period.
The global ultrasound market is projected to reach USD 12.7 billion in 2025 and expand to USD 21.4 billion by 2035, reflecting a CAGR of 6.8% over the forecast period.
The global uncomplicated urinary tract infection (UTI) treatment market is set for significant expansion, projected to reach USD 6.55 billion by 2025 and surge to USD 18 billion by 2035.
The global unilateral biportal endoscopy market is projected to reach USD 905.5 million in 2025 and is expected to grow to USD 1,636.1 million by 2035, reflecting a CAGR of 7.1% over the forecast period.
The global unit dose manufacturing market is projected to grow significantly, reaching USD 33.5 billion by 2025 and expanding to USD 194.3 billion by 2035. The market is expected to witness a CAGR of 20.5% over the forecast period
The United States concierge medicine market is projected to reach USD 7.73 billion in 2025, expanding to USD 18.97 billion by 2035, reflecting a CAGR of 11.32% over the forecast period.
The global unresectable hepatocellular carcinoma (HCC) market is projected to expand significantly, reaching USD 3.2 billion by 2025 and surging to USD 5.4 billion by 2035.